−0.058EUR
−3.35 MEUR
50.76 M
About ORYZON GENOMICS, S.A.
Sector
Industry
CEO
Carlos Manuel Buesa Arjol
Website
Headquarters
Barcelona
Founded
2000
ISIN
ES0167733015
FIGI
BBG000GMXR61
Oryzon Genomics SA is a clinical stage biopharmaceutical company, which engages in the discovery, research, and development of new chemical entities, as well as conducting clinical trials. It focuses on epigenetics in various therapeutic indications, with a special emphasis on oncology and neurodegenerative disease. The firm's product pipelines include Iadademstat and Vafidemstat. The company was founded by Carlos Manuel Buesa Arjol and Tamara Maes on June 2, 2000 and is headquartered in Barcelona, Spain.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ORY is 1.780 EUR — it has decreased by 5.82% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange ORYZON GENOMICS, S.A. stocks are traded under the ticker ORY.
ORYZON GENOMICS, S.A. is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ORYZON GENOMICS, S.A. has a max estimate of 12.000 EUR and a min estimate of 3.000 EUR.
ORY earnings for the last quarter are −0.02 EUR whereas the estimation was −0.04 EUR which accounts for 55.04% surprise. Estimated earnings for the next quarter are −0.05 EUR. See more details about ORYZON GENOMICS, S.A. earnings.
Yes, you can track ORYZON GENOMICS, S.A. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ORY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORYZON GENOMICS, S.A. stock right from TradingView charts — choose your broker and connect to your account.